SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-010650
Filing Date
2018-04-24
Accepted
2018-04-24 16:05:24
Documents
2
Period of Report
2018-04-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1564
2 EX-24 DOCUMENT attachment1.htm EX-24 2514
  Complete submission text file 0000899243-18-010650.txt   5676
Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD, #200 SOUTH SAN FRANCISCO CA 94080
Business Address
Peetz Christopher (Reporting) CIK: 0001614740 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37449 | Film No.: 18771487

Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations